Following years of research by Dr Joseph Cheriyan, Prof Ian Wilkinson, Dr James Rudd, and many others, GlaxoSmithKline (GSK) has announced a new Phase III clinical trial – LATITUDE-TIMI 60 – to test a new losmapimod drug in more than 25,000 patients with acute coronary syndrome.  For more information please click on the links below: […]

Close academic and industry collaborations between GSK and NIHR Cambridge BRC drive forward new clinical trials for heart disease. A new Phase III clinical trial in patients with heart disease has just commenced following years of seminal research work at the NIHR Cambridge Biomedical Research Centre (BRC). The LATITUDE-TIMI 60 trial funded by GlaxoSmithKline (GSK), […]